CoChat

Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study

Gilaberte, Inmaculada, Montejo, Angel Luis, de la Gandara, Jesus, Perez-Sola, Victor, Bernardo, Miguel, Massana, Joan, Martin-Santos, Rocio, Santiso, Alfonso, Noguera, Ramon, Casais, Leonardo, Perez-Camo, Valero, Arias, Manuel, Judge, Rajinder · 2001 · Journal of Clinical Psychopharmacology
Cited by 58

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Optimal outcomes from depression treatment are long-term recovery and, in the case of recurrent depression, prevention of new episodes. However, few data are available concerning the long-term efficacy of antidepressants in prophylactic treatment to prevent recurrences of depression. The efficacy and safety of fluoxetine 20 mg/day was evaluated in reducing the number of depressive episodes and in extending the time free of symptoms in patients with recurrent unipolar major depression. Patients with recurrent unipolar major depression according to DSM-III-R criteria and who responded to 32 weeks of open-label fluoxetine were randomly assigned to receive fluoxetine 20 mg/day (N = 70) or placebo (N = 70) for 48 weeks of double-blind maintenance treatment. Outcome measures were the percentage of recurrences and time to recurrence. Safety assessments included treatment-emergent adverse events, reasons for discontinuation, vital signs, and laboratory measures. Fluoxetine was associated with a statistically significantly smaller percentage of patients who had a recurrence compared with placebo (20% vs. 40%; chi2 analysis, p = 0.010). The symptom-free period was significantly longer for patients treated with fluoxetine versus placebo (295 vs. 192 days; Kaplan-Meier estimates, log-rank test, p = 0.002). Treatments were well tolerated during maintenance treatment. The only statistically significant difference in adverse events between treatment groups was anxiety, which was more frequent in the placebo group (fluoxetine, 12.9% vs. placebo, 30%; chi2 analysis, p = 0.013). Two placebo-treated patients and no fluoxetine-treated patients were withdrawn because of adverse events. In conclusion, fluoxetine at 20 mg/day was effective and well tolerated for the prophylactic treatment of recurrent unipolar major depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-200108000-00009

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 12

  1. Murray, 1997, Lancet, 349, 1436, 10.1016/S0140-6736(96)07495-8 · DOI · Paper page
  2. Thase, 1995, CNS Drugs, 4, 261, 10.2165/00023210-199504040-00004 · DOI
  3. Prien, 1986, Am J Psychiatry, 143, 18, 10.1176/ajp.143.1.18 · DOI · Paper page
  4. Demyttenaere, 1998, Int Clin Psychopharmacol, 13, 11, 10.1097/00004850-199801000-00002 · DOI · Paper page
  5. Montgomery, 1989, Neuropsychobiology, 22, 214, 10.1159/000118619 · doi:10.1159/000118619
  6. Keller, 1998, JAMA, 280, 1665, 10.1001/jama.280.19.1665 · DOI · Paper page
  7. 1985, Am J Psychiatry, 142, 469, 10.1176/ajp.142.4.469 · DOI · Paper page
  8. Frank, 1990, Arch Gen Psychiatry, 47, 1093, 10.1001/archpsyc.1990.01810240013002 · DOI · Paper page
  9. Montgomery, 1993, Int Clin Psychopharmacol, 8, 189, 10.1097/00004850-199300830-00009 · DOI · Paper page
  10. Doogan, 1992, Br J Psychiatry, 160, 217, 10.1192/bjp.160.2.217 · DOI · Paper page
  11. Franchini, 1997, J Clin Psychiatry, 58, 104, 10.4088/JCP.v58n0303 · DOI · Paper page
  12. Reimherr, 1998, Am J Psychiatry, 155, 1247, 10.1176/ajp.155.9.1247 · DOI · Paper page

Cited by

See all 58

Metadata

Authors
Gilaberte, I., Montejo, A. L., de la Gandara, J., Perez-Sola, V., Bernardo, M., Massana, J., Martin-Santos, R., Santiso, A., Noguera, R., Casais, L., Perez-Camo, V., Arias, M., & Judge, R.
Venue
Journal of Clinical Psychopharmacology
Published
2001-08
Volume
21
Issue
4
Pages
417-424
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2063767287
Cited by
58
References
2
FWCI
1.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study. https://app.cochat.ai/papers/10.1097/00004714-200108000-00009
The paper
Gilaberte, I., Montejo, A. L., de la Gandara, J., Perez-Sola, V., Bernardo, M., Massana, J., Martin-Santos, R., Santiso, A., Noguera, R., Casais, L., Perez-Camo, V., Arias, M., & Judge, R. (2001). Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200108000-00009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.